Under normal circumstances, interactions between PD-1 and its ligand PD-L1 can halt or limit the immune system’s response to human cells and suppress...
As product performance and patient safety are central to our values, PerkinElmer is fully prepared to comply with this important transition. If you are a ...
Conventional high-content screening experiments typically focus on extracting imaging data relating to predefined, specific features to identify drugs or d...
Although hybridoma technology remains one of the most common techniques for antibody production, the generation and screening of hybridomas can be time-con...
With its resplendent flowers, the Madagascar periwinkle plant (Catharanthus roseus) easily draws attention to itself, both in a natural setting and in ...
No patient with cancer should be denied care because of social determinants. The equity gap in cancer is costing lives. If we unite and work to...
AAVs make ideal gene therapy vectors due to their small size, genetic simplicity, and low immunogenicity. However, several limitations are hindering the wi...
The gold standard clinical assessment of treatment response is to measure changes in tumor volume over time. Typically, the RECIST (Response Evaluation Cri...
More recently, the CRISPR system has been used to edit human induced pluripotent stem cells (iPSCs), which are known to exhibit phenotypes closer to human ...
Oligonucleotide therapeutics have unlocked new treatment possibilities for rare and fatal diseases often associated with undruggable proteins.1 Here, ...
© 2024 Biopharma Boardroom. All Rights Reserved.
